PKE:NYSEPark Aerospace Corp. Analysis
Data as of 2026-05-25 - not real-time
$34.60
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Park Aerospace (PKE) is trading at $34.6, just below the technical resistance of $35.30 and comfortably above the 20‑day SMA of $33.74, indicating a short‑term bullish bias despite a bearish MACD histogram. Volume is increasing and the 30‑day volatility is high at ~42%, suggesting active trading and price swings. The RSI of 57 points to neutral momentum, while the broader trend remains bullish as the 20‑day SMA sits above both the 50‑day ($31.50) and 200‑day ($23.84) averages. Fundamentally, revenue grew 20% YoY to $66 M with solid margins (gross 31%, operating 21%) and a strong cash position of $63.5 M against minimal debt ($0.3 M). However, the stock’s valuation is extreme: a trailing P/E of 80 versus an industry average of 30, a price‑to‑book of 6.5, and a DCF‑derived fair value of only $6.20. The dividend yield of 1.45% is undermined by a payout ratio above 100%, raising sustainability concerns. The company’s beta of 1.37 and high volatility amplify market risk, while its exposure to North America, Asia, and Europe moderates geographic concentration. Overall, the market appears to price PKE far beyond its intrinsic fundamentals, creating a mismatch between price momentum and underlying value.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical resistance at $35.30
- Bearish MACD divergence despite bullish SMA alignment
- Extreme valuation metrics (P/E 80, DCF $6.20)
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong revenue growth (20% YoY) and solid cash balance
- Persistent overvaluation relative to industry peers
- High volatility and beta indicating price sensitivity
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Fundamental valuation gap (DCF fair value $6.20 vs market $34.6)
- Unsustainable dividend payout (>100% of earnings)
- Elevated market risk from beta and 30‑day volatility
Key Metrics & Analysis
Financial Health
Revenue Growth20.30%
Profit Margin13.14%
P/E Ratio80.5
ROE8.11%
ROA6.08%
Debt/Equity0.31
P/B Ratio6.5
Op. Cash Flow$5.5M
Free Cash Flow$2.0M
Industry P/E29.7
Technical Analysis
TrendBullish
RSI57.6
Support$31.70
Resistance$35.30
MA 20$33.74
MA 50$31.50
MA 200$23.84
MACDBearish
VolumeIncreasing
Fear & Greed Index91.64
Valuation
Fair Value$6.21
GradeOvervalued
TypeGrowth
Dividend Yield1.45%
Risk Assessment
Beta1.37
Volatility41.94%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.